Psychedelic Therapy in Georgia, Tennessee & the Carolinas: Access Now

The Baseline: What Federal Law Still Controls

Before looking at individual states, it helps to understand the floor. Under the federal Controlled Substances Act, psilocybin is still Schedule I, meaning no approved clinical use and no prescriptions. Ketamine is Schedule III and FDA-approved, which is why it is the only psychedelic-adjacent therapy you can walk into a licensed clinic and receive today in most of the country. For a broader picture of how federal law interacts with state reform, see our overview: Is Psychedelic Therapy Legal in the United States?

That federal baseline is what shapes everything in the Southeast right now. Georgia, Tennessee, North Carolina, and South Carolina are all conservative-leaning states where psilocybin reform has not passed. But that does not mean the region is standing still.

Georgia: Ketamine Access Is Real, and a Regulatory Shift Is Underway

Atlanta has developed a meaningful ketamine clinic ecosystem. Multiple providers now offer both IV ketamine infusions for treatment-resistant depression, PTSD, and anxiety, as well as Spravato (esketamine), the FDA-approved nasal spray that carries insurance coverage in qualifying cases. The Atlanta market operates with both cash-pay and insured pathways, and clinics serving surrounding metro communities including Alpharetta, Marietta, Decatur, and Roswell have become increasingly accessible.

The more significant development in Georgia is legislative. In early 2026, Georgia HB 717 passed both chambers with overwhelming margins, 153 to 3 in the House and 50 to 1 in the Senate. The bill amends the Medical Practice Act to create a formal regulatory framework for psychedelic-assisted treatment and therapy clinics, including ketamine. The Georgia Composite Medical Board is required to establish rules and safety standards by December 31, 2026, with all clinics required to hold a license by July 1, 2027.

What this means practically: Georgia is not legalizing psilocybin. HB 717 is scoped to FDA-approved substances, which currently means ketamine. But the framework it creates would allow additional substances to be incorporated as they receive FDA clearance. It also establishes standards around practitioner training, emergency protocols, and clinic safety that most existing ketamine clinics will need to meet. For seekers, this is ultimately a patient protection measure, and it signals that Georgia intends to be a regulated, not restrictive, environment for this category of care.

On psilocybin specifically: Georgia has no decriminalization, no therapeutic program, and no bill targeting psilocybin access in the current session. Anyone in Atlanta exploring psychedelic therapy beyond ketamine today is either traveling to Oregon or Colorado (where licensed psilocybin service centers operate legally), working with a guide in legally ambiguous contexts, or considering international retreat options.

Tennessee: Ketamine in Nashville, Ibogaine on the Horizon

Nashville’s ketamine therapy landscape is well-developed. Clinics in the metro area treat depression, PTSD, anxiety, and chronic pain, with several holding Spravato REMS certification for the FDA-approved esketamine nasal spray. The city functions as a regional hub for ketamine therapy Nashville residents and those coming from across Middle Tennessee and neighboring states.

Tennessee’s broader psychedelic policy conversation has taken an interesting turn in 2026. The state legislature passed HB 2075, the Helping Open Pathways to Effective (HOPE) Treatment Act, a bill that allows Tennessee research universities and hospitals to participate in multistate ibogaine clinical trial consortiums. Ibogaine, derived from the root bark of a Central African shrub, has shown early research promise for opioid use disorder, PTSD, and traumatic brain injury, including a 2025 Stanford study involving special operations veterans that produced striking results on validated symptom measures. The Tennessee bill was shaped in part by alignment with a Trump executive order directing federal agencies to accelerate psychedelic research, and passed with bipartisan support.

For practical purposes, Tennessee remains fully restrictive on psilocybin. There is no decriminalization and no clinical access. The HOPE Act signals that the state is interested in research and in treating veterans and people with addiction, but it does not create any immediate public access to psychedelic-assisted therapy beyond what is already available through ketamine. Anyone in Nashville seeking a fuller psychedelic therapy experience will need to look outside state lines or work with a guide who can support preparation and integration around legal options.

North Carolina: Asheville as an Unlikely Hub, Charlotte as a Ketamine Market

North Carolina’s legal position is straightforward: psilocybin is Schedule I under both state and federal law, no reform has passed, and no decriminalization bill has advanced. That is the legal reality.

The cultural reality in Asheville is somewhat different. The city has a long history of openness to alternative and integrative medicine, and it has developed a visible community around psychedelic preparation and integration. Several licensed ketamine clinics operate in the Asheville area offering ketamine-assisted psychotherapy, including providers who combine IV or intramuscular ketamine with formal psychotherapy sessions in what the field calls KAP (ketamine-assisted psychotherapy). Costs for a full protocol typically range from roughly $2,500 to $3,500 depending on the provider and number of sessions, with psychotherapy integrated throughout. For anyone serious about psilocybin therapy Asheville is a reasonable base for preparation, integration work, and ketamine access, even if the psilocybin itself requires traveling to a legal jurisdiction.

Charlotte functions more like Atlanta than Asheville in this context: a large metro with a developing ketamine clinic market, more medical in orientation, less rooted in the integrative therapy culture that has taken hold in the mountains. For Charlotte-area seekers, the path to psychedelic therapy in 2026 runs through ketamine clinics, integration therapists, and, for those committed to psilocybin, either Oregon, Colorado, or international retreat destinations.

On legislation: North Carolina has seen some research-oriented bill activity, including proposals around funding studies on psilocybin for anxiety and depression, but none have advanced to a vote in the current session.

South Carolina: No Reform, Ketamine Access Exists

South Carolina has passed no psychedelic reform as of May 2026 and has no active legislation progressing through the legislature. Federal law applies entirely. Ketamine therapy is available via licensed providers in the state, primarily in Charleston and Columbia, but anyone in South Carolina seeking anything beyond ketamine-based treatment is in the same position as seekers in Georgia and Tennessee: legal options require either traveling to regulated states or working with a guide who focuses on preparation, harm reduction, and integration support rather than substance access.

Retreat Tourism: The Asheville Question

Asheville consistently appears on retreat listings and search results for psilocybin therapy in the Southeast, and it is worth being direct about what that reflects. Retreat listings that show up for North Carolina generally involve either legal psilocybin (Oregon, Netherlands, Jamaica, Mexico) accessed through travel, ketamine-based experiences delivered by licensed North Carolina providers, or integration-focused retreats that work with clients who have already had an experience elsewhere.

What Asheville genuinely offers is a concentrated community of trained integration therapists, KAP providers, and practitioners who understand psychedelic experiences. For someone returning from a legal psilocybin retreat in Oregon and wanting to work through what they encountered, Asheville has more relevant support than almost any other city in the Southeast. That is not nothing. Integration is where a lot of the therapeutic value actually lands, and a geographically accessible community of competent practitioners matters.

What to Do Right Now

If you are in Georgia, Tennessee, or the Carolinas and are seriously exploring psychedelic-assisted therapy, the most useful first step is not a web search for local clinics. It is a conversation with someone who can help you understand your actual options given your history, your goals, and your circumstances.

Ketamine therapy is genuinely available and genuinely effective for a significant number of people. It is not a second-best substitute for psilocybin; it is a distinct treatment with its own profile of evidence and its own risks. Whether it is the right starting point for you depends on information a checklist cannot provide.

For those who have already determined that a psilocybin-assisted experience is what they are looking for, traveling to a legal jurisdiction is the responsible path. Oregon and Colorado both have operational licensed programs. The planning, preparation, and integration support around that experience is where a concierge service provides the most value, and where the difference between a well-supported experience and a poorly-supported one is most significant.

JourneyŌM works with seekers across the Southeast to navigate these questions. We match people with vetted guides and support the full arc of preparation, experience, and integration, regardless of which state you are in. We understand the regulatory landscape and do not cut corners on safety or vetting.